BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tang SY, Tan JS, Pang XZ, Lee GH. Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact. World J Gastroenterol 2023; 29(3): 549-560 [PMID: 36688021 DOI: 10.3748/wjg.v29.i3.549]
URL: https://www.wjgnet.com/1007-9327/full/v29/i3/549.htm
Number Citing Articles
1
Muhammed Mubarak. Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunitiesWorld Journal of Gastrointestinal Pathophysiology 2024; 15(1): 92864 doi: 10.4291/wjgp.v15.i1.92864
2
Dongmin Liu, Siyu Wang, Yaqing Liu, Yong Luo, Beibei Wen, Wenliang Wu, Hongliang Zeng, Jianan Huang, Zhonghua Liu. Fuzhuan brick tea ameliorates hepatic steatosis and steatohepatitis through gut microbiota-derived aryl hydrocarbon receptor ligands in high-fat diet-induced obese miceFood & Function 2023; 14(18): 8351 doi: 10.1039/D3FO01782F
3
Tianran Shen, Shupei Wang, Zhihao Wang, Hanlu Jia, Yuan Wei, Yu Li, Qiutong Zheng, Yuting Li, Luanzhao Pan, Qingsong Chen. Association between the traditional Chinese medicine constitution and metabolic dysfunction-associated fatty liver disease in older people: A cross-sectional studyHeliyon 2024; 10(3): e24905 doi: 10.1016/j.heliyon.2024.e24905
4
Lei Liu, Yufu Zhou, Shuwen Deng, Ting Yuan, Saiqi Yang, Xiaoling Zhu, Changfa Wang, Yaqin Wang. Arterial stiffness progression in metabolic dysfunction–associated fatty liver disease subtypes: A prospective cohort studyNutrition, Metabolism and Cardiovascular Diseases 2024;  doi: 10.1016/j.numecd.2024.03.030